
Indapamide (1.5mg) + Telmisartan (40mg)
Active composition
+1 more active ingredient
Indapamide inhibits sodium reabsorption in the distal convoluted tubule, promoting diuresis and lowering blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Indipil T Tablet SR is a combination antihypertensive medication containing Telmisartan 40 mg and Indapamide 1.5 mg, formulated to provide sustained-release action for effective blood pressure control. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby preventing vasoconstriction and aldosterone secretion, resulting in vasodilation and reduced blood pressure. Indapamide, a thiazide-like diuretic, promotes natriuresis and diuresis by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, reducing plasma volume and peripheral resistance. The combination of these two agents offers complementary mechanisms that enhance antihypertensive efficacy while minimizing electrolyte imbalances commonly associated with diuretics alone. Indipil T Tablet SR is indicated for the management of essential hypertension, particularly in patients who require dual therapy to achieve target blood pressure levels. The sustained-release formulation ensures a gradual and prolonged drug release, improving patient compliance and maintaining stable plasma concentrations throughout the dosing interval. This medication should be used under medical supervision with regular monitoring of blood pressure, renal function, and electrolytes to optimize therapeutic outcomes and minimize potential adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Indipil T Tablet SR is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Indipil T Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Indipil T Tablet SR should be used with caution in patients with severe kidney disease. Dose adjustment of Indipil T Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Indipil T Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Indipil T Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Indipil T Tablet SR may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Indipil T Tablet SR

Telmisartan (40mg) + Indapamide (1.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Indapamide inhibits sodium reabsorption in the distal convoluted tubule, promoting diuresis and lowering blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Indipil T Tablet SR is a combination antihypertensive medication containing Telmisartan 40 mg and Indapamide 1.5 mg, formulated to provide sustained-release action for effective blood pressure control. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby preventing vasoconstriction and aldosterone secretion, resulting in vasodilation and reduced blood pressure. Indapamide, a thiazide-like diuretic, promotes natriuresis and diuresis by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, reducing plasma volume and peripheral resistance. The combination of these two agents offers complementary mechanisms that enhance antihypertensive efficacy while minimizing electrolyte imbalances commonly associated with diuretics alone. Indipil T Tablet SR is indicated for the management of essential hypertension, particularly in patients who require dual therapy to achieve target blood pressure levels. The sustained-release formulation ensures a gradual and prolonged drug release, improving patient compliance and maintaining stable plasma concentrations throughout the dosing interval. This medication should be used under medical supervision with regular monitoring of blood pressure, renal function, and electrolytes to optimize therapeutic outcomes and minimize potential adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Indipil T Tablet SR is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Indipil T Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Indipil T Tablet SR should be used with caution in patients with severe kidney disease. Dose adjustment of Indipil T Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Indipil T Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Indipil T Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Indipil T Tablet SR may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Indipil T Tablet SR















